Animal and organoid models to elucidate the anti-fibrotic effect of steroid on biliary atresia
Topic overview
This study uses rhesus rotavirus-induced mouse models and liver organoids to demonstrate that corticosteroid treatment significantly reduces liver fibrosis in biliary atresia. Steroid-treated mice showed improved weight gain, lower bilirubin levels, and markedly reduced fibrosis compared to controls, with RNA sequencing revealing over 6000 differentially expressed genes between treatment groups.
Key takeaways
- Steroid treatment significantly reduced liver fibrosis in RRV-induced biliary atresia mouse models (1/12 vs 12/12 developed fibrosis).
- Steroid-treated BA mice showed improved weight gain and significantly lower serum bilirubin and liver enzyme levels compared to controls.
- Liver organoid models demonstrated distinct morphological differences and 6359 differentially expressed genes with steroid treatment.
- Animal and organoid models provide complementary evidence that steroids may have anti-fibrotic therapeutic potential in biliary atresia.
- Post-Kasai steroid therapy warrants further investigation based on these preclinical findings showing fibrosis mitigation.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Animal and organoid models to elucidate the anti-fibrotic effect of steroid on biliary atresia. GlobalCastMD Medical Library. 2024-08-05. https://dev.library.globalcastmd.com/article/8960?via_space=staycurrentmd
Comments